<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01526655</url>
  </required_header>
  <id_info>
    <org_study_id>ROBOTHYST</org_study_id>
    <nct_id>NCT01526655</nct_id>
  </id_info>
  <brief_title>Robot Assisted Laparoscopic Hysterectomy vs. Abdominal Hysterectomy in Endometrial Cancer</brief_title>
  <official_title>A Randomized Open Controlled Trial Comparing Robot Assisted Laparoscopic Hysterectomy and Abdominal Hysterectomy for Endometrial Cancer in a Fast Track Program</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Linkoeping</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Linkoeping</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the trial is to determine whether robot assisted laparoscopic hysterectomy
      compared with abdominal hysterectomy in a fast track program gives a faster recovery
      postoperatively, causes less tissue damage and less effects on the immunological system, and
      is health economically cost-effective.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      If detailed description is requested, please contact sponsor.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Six weeks</time_frame>
    <description>Quality of life measured by means of the Euroqol form (EQ-5D) and the Short form 36 (SF-36). The EQ-5D form is filled in on one occasion one week preoperatively, then daily in a week from the evening after surgery, then once weekly for additional five weeks. The SF-36 is filled in one week preoperatively and six weeks postoperatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in biomarkers for tissue damage</measure>
    <time_frame>During six weeks</time_frame>
    <description>The biomarkers (high sensitive -C reactive protein (hs-CRP), creatin kinase (CK), high-mobility group protein B1 (HMGB1) and aminoacids (glutamin, glutamate, citruline, arginine, ornithine, aspartate and taurine))are measured preoperatively, 2, 24 and 48 hours after surgery, and 1 and 6 weeks postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in cytokines and chemokines</measure>
    <time_frame>During six weeks</time_frame>
    <description>The proinflammatory cytokines (interleukine-1 (IL-1), interleukine-6 (IL-6), interleukine 8 (CXCL8), tumour necrosis factor-alpha (TNF-alpha)), the antiinflammatory cytokine (interleukine-10 (IL-10)) and the Th-1 mediated inflammatory chemokine (CXCL10) are measured preoperatively, 2, 24 and 48 hours after surgery, and 1 and 6 weeks postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in amount and function of T, B and natural killer(NK) lymphocytes</measure>
    <time_frame>During six weeks</time_frame>
    <description>Blood samples are collected on three occasions: one week preoperatively, one and six weeks postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative symptoms</measure>
    <time_frame>Six weeks</time_frame>
    <description>Symptoms are self-reported in the Swedish Postoperative Symptom Questionnaire. The questionnaire are filled in on one occasion one week preoperatively, then once daily for a week from day of surgery; thereafter once weekly for additional five weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consumption of analgesic</measure>
    <time_frame>Six weeks</time_frame>
    <description>Use of analgesics is registered during hospital stay. After discharge the patient makes notes in a study specific diary of the daily consumption of analgesic until the six weeks visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health economics</measure>
    <time_frame>Six weeks</time_frame>
    <description>Direct and indirect costs for hospital stay and recovery period until six weeks postoperatively. Quality-adjusted life years (QALY) and cost-effectiveness are determined.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>Six weeks</time_frame>
    <description>Adverse events (AE) and serious adverse events (SAE) are registered systematically from start of anesthesia to six weeks postoperatively</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Endometrial Cancer</condition>
  <arm_group>
    <arm_group_label>Abdominal total hysterectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard extrafascial abdominal total hysterectomy through a low transverse abdominal wall incision</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Robot assisted laparoscopic hysterectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Robot assisted laparoscopic total hysterectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Abdominal total hysterectomy</intervention_name>
    <description>Abdominal total hysterectomy through a low transverse abdominal wall incision</description>
    <arm_group_label>Abdominal total hysterectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Robot assisted laparoscopic hysterectomy</intervention_name>
    <description>Robot assisted laparoscopic total hysterectomy</description>
    <arm_group_label>Robot assisted laparoscopic hysterectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 18 years of age.

          -  Scheduled to total hysterectomy + bilateral salpingooophorectomy (BSAE) and peritoneal
             lavage because of endometrial carcinoma, International federation of gynecology and
             obstetrics (FIGO) stage 1, grade 1 and 2, with diploid DNA profile (i.e. low risk
             profile).

          -  WHO performance status ≤ 2.

          -  Proficiency in Swedish

          -  Accept to participate in the study and has signed written informed consent document.

          -  The operation should be considered possible to be perform laparoscopically and by
             laparotomy through a low transverse abdominal wall incision.

        Exclusion Criteria:

          -  The operation is anticipated to comprise more than the hysterectomy + BSAE.

          -  A midline incision is planned for the laparotomy.

          -  Contraindications towards spinal anesthesia with intrathecally applied morphine.

          -  Physically disabled women who cannot be expected to be mobilized in accordance to the
             fast track program in a way similar to what is expected from not-physically disabled
             women.

          -  Mentally disabled women who cannot fill in the questionnaires or understand the
             consequences of participating in a trial.

          -  Severe psychiatric disease or on medication for psychiatric disease so that the
             physician consider participation in the trial inappropriate.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Preben Kjölhede, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Obstetrics and Gynecology, University Hospital, 58185 Linköping, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Evelyn Lundin, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Obstetrics and Gynecology, University Hospital, 58185 Linköping, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ninnie Borendal Wodlin, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Obstetrics and Gynecology, University Hospital, 58185 Linköping, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lena Nilsson, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anesthesiology, University Hospital, 58185 Linköping, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jan Ernerudh, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Clinical Immunology, University Hospital, 58185 Linköping, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Per Carlsson, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Centre for Medical Technology Assessment, University Hospital, 58185 Linköping, Sweden</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Preben Kjölhede, MD, PhD</last_name>
    <phone>+46101030000</phone>
    <phone_ext>3187</phone_ext>
    <email>Preben.Kjolhede@regionostergotland.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Evelyn Lundin, MD</last_name>
    <phone>+46101030000</phone>
    <email>Evelyn.Lundin@regionostergotland.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology, Ryhov Central Hospital</name>
      <address>
        <city>Jönköping</city>
        <state>Jönköpings län</state>
        <zip>551 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laila Falknäs, MD</last_name>
      <phone>+4636321000</phone>
      <email>Laila.Falknas@lj.se</email>
    </contact>
    <contact_backup>
      <last_name>Johan Skoglund, MD</last_name>
      <phone>+4636321000</phone>
      <email>Johan.Skoglund@lj.se</email>
    </contact_backup>
    <investigator>
      <last_name>Laila Falknäs, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Johan Skoglund, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology, University Hospital</name>
      <address>
        <city>Linköping</city>
        <state>Östergötland</state>
        <zip>58185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Preben Kjölhede, MD, PhD</last_name>
      <phone>+46101030000</phone>
      <phone_ext>3187</phone_ext>
      <email>Preben.Kjolhede@regionostergotland.se</email>
    </contact>
    <contact_backup>
      <last_name>Evelyn Lundin, MD</last_name>
      <phone>+46101030000</phone>
      <email>Evelyn.Lundin@regionostergotland.se</email>
    </contact_backup>
    <investigator>
      <last_name>Preben Kjölhede, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Evelyn Lundin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shefqet Halili, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Lukas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gulnara Kassymova, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ninnie Borendal Wodlin, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2012</study_first_submitted>
  <study_first_submitted_qc>February 1, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2012</study_first_posted>
  <last_update_submitted>February 20, 2016</last_update_submitted>
  <last_update_submitted_qc>February 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Linkoeping</investigator_affiliation>
    <investigator_full_name>Preben Kjolhede</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Endometrial cancer</keyword>
  <keyword>Robot assisted laparoscopy</keyword>
  <keyword>Abdominal hysterectomy</keyword>
  <keyword>Fast track program</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometrial Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

